Transdermal oestradiol patches are non-inferior to luteinising hormone-releasing hormone agonists for metastasis free survival in locally advanced prostate cancer, a study shows.
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...
Add Yahoo as a preferred source to see more of our stories on Google. A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
MedPage Today on MSN
Estradiol Patch Matches LHRH Agonists for Locally Advanced Prostate Cancer
Similar 3-year metastasis-free survival, fewer hot flashes, more gynecomastia ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...
The Prostate Cancer Foundation (PCF) today announced the launch of the Hästens-PCF Global Health Award, a new initiative designed to advance equitable prostate cancer detection, diagnosis, and care in ...
Hyderabad is witnessing a rise in advanced-stage prostate cancer due to low screening rates and lifestyle factors. Experts ...
Add Yahoo as a preferred source to see more of our stories on Google. Joe Biden's Cancer Moonshot initiative had funded hundreds of cancer research projects across the country. AP Photo/Gerald Herbert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results